The PD-1:PD-L pathway plays a major role in regulating T cell exhaustion during chronic viral infections in animal models as well as in humans and 
Introduction
Chronic viral infections are often associated with CD8+ T cell dysfunction (30) . This dysfunction, termed exhaustion, includes defects in the ability to produce antiviral cytokines, poor cytotoxicity, a loss of antigen independent self renewal and the inability to vigorously re-expand following antigen exposure (30) .
These functional deficiencies contrast with the highly functional memory CD8+ T cells that are generated following acute infection and maintained via IL-7 and IL-15 mediated homeostatic proliferation (30) . During chronic viral infections, T cell exhaustion often correlates with poor control of viral replication (3, 8, 38, 39) .
Thus, there is considerable interest in developing strategies to reverse exhaustion and restore function in virus-specific CD8+ T cells during chronic infections.
Recent studies have revealed an important role for the negative regulatory molecule PD-1 in CD8 T cell exhaustion during chronic viral infections (29) . PD-1, a member of the CD28/CTLA-4 family of costimulatory/co-inhibitory receptors, contains both ITIM and ITSM motifs in the intracellular tail and can deliver negative signals, at least partly via recruitment of the phosphatase Shp-2 (29) . A role for PD-1 in regulating T cell responses to chronic viral infections was first observed using LCMV infection of mice where PD-1 was found to be highly expressed on exhausted CD8+ T cells from chronically infected animals but not on functional memory CD8+ T cells from mice that had cleared an acute strain of the virus (3) . In vivo blockade of the PD-1 pathway led to a dramatic increase in the number of virus-specific CD8+ T cells, improved functionality of these cells (6-8, 24, 26, 32, 33, 42) . Increasing PD-1 expression also correlates with disease status during HIV infection (8, 42) . In vitro blockade of PD-1:PD-L interactions can reinvigorate exhausted virusspecific T cell responses in humans and appears to have a prominent impact on proliferative expansion and/or prevention of apoptosis in these cases (9, 24, 32) .
Finally, recent results from in vivo blockade in the macaque SIV infection model demonstrated the effectiveness of blocking PD-1 in primates during chronic viral infection (36) . In these studies, PD-1 blockade enhanced virus-specific T and B cell responses, lowered viral load and improved survival of chronically infected animals. Thus, PD-1 has emerged as not only a major regulator of T cell exhaustion and viral control during chronic infection, but also as an important potential therapeutic target.
Despite these important studies and the clear impact of PD-1 blockade on reversal of T cell exhaustion, important questions remain. For example, previous work has demonstrated that PD-1 expression is not uniform on subsets of exhausted CD8 T cells (4) . However, the expression of PD-1 on exhausted CD8
T cells in multiple tissues, and the relationship between PD-1 expression in these tissues to viral load, the PD-1 ligands and function has not been examined.
Given the non-lymphoid accumulation of virus-specific CD8 T cells during chronic on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from viral infections (11, 39) and the predilection of many important chronic infections for replicating in anatomically restricted locations (e.g. HCV and the liver, HIV and mucosal tissues, etc), the dynamics of PD-1 expression by exhausted CD8 T cells outside the blood and spleen could have important therapeutic implications.
In the present study we examined these issues using the mouse model of 
Materials and Methods

Mice, virus and infections.
C57Bl/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
LCMV Armstrong and clone 13 strains were propagated, titered and used as described (2) . Briefly, LCMV titers were measured by plaque assay on vero cell monolayers. Vero cells were plated in 35-mm wells in 6-well dishes, incubated at 37°C and used the following day when the cell monolayers were confluent. The medium was removed and the samples to be titrated were added to the cells (0.2 ml). After adsorption for 60 min at 37°C, the cells were overlaid with 4 ml of a 50:50 mixture of 0.5% Seakem agarose (Lonza, Rockland, ME) and 2x Medium or i.v. with LCMV clone 13 (2x10 6 p.f.u). All mice were used in accordance with
Institutional Animal Care and Use Committee guidelines.
Isolation of Lymphocytes from tissues.
Lymphocytes were isolated from non-lymphoid tissues as described (39) . Briefly, mice were euthanized, the hepatic vein cut and the liver perfused with 5 ml of ice cold PBS. Lungs were harvested by cutting the left ventricle and injecting PBS into the right ventricle to perfuse the lungs. Liver, lung, and kidney tissue was on August 30, 2017 by guest http://jvi.asm.org/
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homogenized using a wire screen. Homogenized lung was first incubated in 1.5 mM EDTA at 37 °C for 30 min and liver, lung, and kidney were then incubated in 0.25 mg/ml collagenase B (Boehringer Mannheim) and 1 U/ml DNase (Sigma) at 37 °C for 45 min. Digested tissue was applied to a 44/56% Percoll gradient and centrifuged at 850g for 20 min at 20 °C. The intrahepatic lymphocyte population was harvested from the interface, red blood cells were lysed using 0.83% ammonium chloride and washed, and the resulting lymphocytes counted. Brains were removed and homogenized using a wire screen. The homogenate was adjusted to 30% Percoll and underlaid with 70% Percoll. The Percoll gradient was centrifuged at 800 x g for 20 min at 20°C. Mononuclear cells were recovered from the interface and washed once in RPMI, red blood cells were lysed using 0.83% ammonium chloride, and the cells were washed and counted. BM lymphocytes were isolated by flushing each femur with 5 ml of cold RPMI.
Spleens and lymph nodes were homogenized using a wire screen and red blood cells were lysed using 0.83% ammonium chloride and washed.
8
mice were stained as previously described. For intracellular cytokine analysis, 1 x10 6 splenocytes were cultured in the absence or presence of the indicated peptide (0.2 µg/ml) and brefeldin A for 5-6 h at 37°C. Following staining for surface antigens as described above, cells were stained for intracellular cytokines using the Cytofix/Cytoperm kit (BD/Pharmingen). The CD107a assay was performed as previously described (5). Samples were collected using a conjugated to A647. The staining was carried out using the BD cytofix/cytoperm kit. The alexa 647 conjugation was carried out using the alexa fluor labeling kit (invitrogen) as per the manufacturers instructions.
In vitro apoptosis assay
Measurement of in vitro apoptosis was performed essentially as previously described (4).
Results
PD-1 expression on virus specific CD8+ T cells varies by anatomical location.
During chronic viral infections, antigen-specific CD8+ T cells accumulate to high 
Presence of infectious virus is not the sole determinant of PD-1 expression
Viral load has been correlated with PD-1 expression in a number of studies (8, 31, 35, 42) . To determine if PD-1 expression on LCMV specific CD8+
T cells correlated with the presence of viral replication in the tissues analyzed in 
PD-L1 expression differs between the spleen and bone marrow
A second factor that could influence PD-1 expression in different tissues is the show a trend to increase the frequency of IFN- producers derived from the spleen by ~15%, though this difference was not statistically significant ( Figure   7B ). Thus, it is possible that cytokine production by exhausted CD8+ T cells could be regulated by the PD-1:PD-L1 pathway either by a direct impact on cytokine production or through increased survival of cytokine producing CD8+ T cells. However, the impact in the short term is modest, in contrast to the robust improvement observed after 2 weeks of blockade in vivo (3) (4) (5) 36) .
Exhausted CD8+ T cells from different tissues vary in cytotoxic potential.
In addition to cytokine production, cytotoxicity is a crucial function of CD8
T cells that correlates with long-term control of chronic viral infections (19, 20, 43) . To directly examine cytotoxicity ex vivo, we performed a VITAL killing assay for exhausted CD8 T cells from the different tissues of chronically infected mice (12) . As expected, virus-specific CD8+ T cells generated following LCMV Arm infection (day 10 p.i.) were highly cytolytic in this assay ( Figure 8A ). When (3-5, 8, 9, 24, 25, 32, 36, 42) . These studies suggest that either selective expansion and/or survival or re-programming of exhausted CD8 T cells must occur before enhanced per cell function is achieved.
These concepts are consistent with the notion that T cell exhaustion is a state of differentiation (40) and that relieving a proximal signaling defect by PD-1 blockade might not on its own be sufficient to restore function. Our data is most consistent with the latter ideas since blocking the PD-1 pathway using αPD-L1 in 
